Exciting news! The nomination process for the 2023 AIM-HI Beacon Award for Women Leaders in Oncology is now open through May 31!
The AIM-HI Accelerator Fund (AIM-HI) wants to work with you to elevate, amplify, and celebrate women leaders in all health and life science sectors. We invite you to nominate an inspiring woman leader who has made a remarkable difference in saving and improving the lives of cancer patients.
The 2023 Beacon Award recipient will be awarded an authentic gold medal and honored at a Luncheon Award Ceremony at the National Press Club in Washington DC on October 21, 2023.
This award is designed to recognize trailblazing women leaders who have significantly impacted cancer patients worldwide through the development and commercialization of novel technologies, advocacy, and/or implementation of public policy.
Nominations will be reviewed and evaluated by a distinguished Beacon Award Selection Committee, comprising of physician-scientists, successful entrepreneurs, and prominent business leaders in the health & life sciences industry, according to the following criteria:
- Sustained commitment and leadership for cancer research, development and commercialization of innovative products
- Advocacy for and implementation of public policy to benefit cancer patients
Encouragment, advocacy and inspiration of other women - Impact on cancer patients, their families and community
Learn more and submit an online nomination here.
